Cargando…
Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options
INTRODUCTION: A scaled-up treatment cascade with direct-acting antiviral (DAA) therapy is necessary to achieve global WHO targets for hepatitis C virus (HCV) elimination in Malaysia. Recently, limited access to sofosbuvir/daclatasvir (SOF/DAC) is available through compulsory licensing, with access t...
Autores principales: | Azzeri, Amirah, Dahlui, Maznah, Mohamed, Rosmawati, McDonald, Scott Alexander, Jaafar, Hafiz, Shabaruddin, Fatiha Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015636/ https://www.ncbi.nlm.nih.gov/pubmed/36935675 http://dx.doi.org/10.3389/fpubh.2023.1114560 |
Ejemplares similares
-
Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
por: Mohamed, Rosmawati, et al.
Publicado: (2019) -
Hepatocellular Carcinoma in Malaysia and Its Changing Trend
por: Raihan, Ruksana, et al.
Publicado: (2018) -
Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia
por: McDonald, Scott A., et al.
Publicado: (2015) -
The Burden of Out-of-Pocket Expenditure Related to Gynaecological Cancer in Malaysia
por: Liew, Chee Hui, et al.
Publicado: (2022) -
A Review of Published Literature Regarding Health Issues of Coastal Communities in Sabah, Malaysia
por: Azzeri, Amirah, et al.
Publicado: (2020)